Estimating the prevalence of generalized and partial lipodystrophy: findings and challenges

Overview of attention for article published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, September 2017

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

policy: 1 policy source
twitter: 2 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 94 Dimensions

Readers on

mendeley: 100 Mendeley

Summary Policy documents X Facebook Dimensions citations

So far, Dimensions has found 94 publications that cite this research output.

94

The most recent citing publications are shown below. View all 94 publications that cite this research output on Dimensions.

A multicenter, open‐label, single‐arm trial of the long‐term safety of empagliflozin treatment for refractory diabetes mellitus with insulin resistance (EMPIRE‐02)

Article in Journal of Diabetes Investigation (May 2024)

Diagnostic and referral pathways in patients with rare lipodystrophy and insulin-resistance syndromes: key milestones assessed from a national reference center

Article in Orphanet Journal of Rare Diseases (April 2024)

Analysis of disease characteristics of a large patient cohort with congenital generalized lipodystrophy from the Middle East and North Africa

Article in Orphanet Journal of Rare Diseases (March 2024)